Home | Business News | Browse by Publication | P | Pharma Marketletter

Cymbalta: less impact on sex than Lexapro.

Publication: Pharma Marketletter
Publication Date: 29-MAY-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
US pharmaceutical major Eli Lilly says that new data presented at the American Psychiatric Association's annual meeting suggest that male patients with major depressive disorder treated with Cymbalta (duloxetine) had significantly better sexual functioning when compared to those taking H Lundbeck's selective serotonin reuptake inhibitor Lexapro (escitalopram) within the...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Senior appointments at Neurochem., May 29, 2006
Study shows atomoxetine's efficacy as ADHD treatment., May 29, 2006
Roche's Copegus/Pegasys "cost effective," study., May 29, 2006
DDW 2006 sees presentations on new and established IBS drugs and advan..., May 29, 2006
Nexium reduces aspirin's GI complications., May 29, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.